Heidelberg Institute for Stem Cell Technology and Experimental Medicine

Recent papers from Heidelberg Institute for Stem Cell Technology and Experimental Medicine

1. +A CAR T cell-amplified suppressive B cell circuit in AML2026
2. Concentrating cell-type-specific transcriptional signatures in bone marrow from interspecies comparisonsCell Genomics · 2026
3. Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic targetCell stem cell · 2026
4. Megakaryocyte emperipolesis arms neutrophils via intracellular provisioning2026
5. Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironmentCancer Cell · 2026
6. WNT-driven immune evasion promotes malignant transformation of BRAF-mutant colorectal cancerGastroenterology · 2026
7. Influence of IGF2BP3 on t(4;11) fusion mRNA and protein abundanceLeukemia Research · 2026
8. Clinical decision support in hematological malignancies using a case-grounded AI agentNature Medicine · 2026
9. Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progressionNature Communications · 2026
10. Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party studyLeukemia · 2026
11. Multiome-based identification of molecular markers for prospective identification of platelet-biased HSCsStem Cell Reports · 2026
12. Mapping the genomic and transcriptomic features associated with telomere maintenance mechanisms in complex karyotype sarcomas2026
13. Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsScience Translational Medicine · 2026
14. Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLCell stem cell · 2026
15. Cancer neuroscience: The past, the present, and the road aheadCell · 2026
16. Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorNature Communications · 2026
17. Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyNature Communications · 2026
18. Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingBritish Journal of Cancer · 2026
19. Abstract 1803: Dynamic copy number changes and de novo generation of extrachromosomal DNA modulate therapy resistance.Cancer Research · 2026
20. Abstract 7444: Tetraspanin-driven metabolic plasticity and chemoresistance in disseminated breast cancer cellsCancer Research · 2026